MIAMI – Miami Marlins rookie right-hander Paul Campbell was suspended 80 games Monday after testing positive for an anabolic steroid in violation of the Major League Baseball drug program.
The suspension involving the performance-enhancing drug dehydrochloromethyltestosterone was immediately effective, MLB said.
Campbell, 25, a December Rule 5 acquisition from the Tampa Bay Rays, said he never consciously ingested the PED, hadn’t even heard of it.
“Due to the fact that I do not know the origin of how this substance has entered my system, I do not currently have a viable defense,” Campbell said in a statement.
“Unfortunately, I have become one of the many athletes, in multiple sports, who are presenting themselves to the world and asking members of the anti-doping world to help us find answers as to why this metabolite continues to appear in athletes’ bodies and, Ultimately, it costs them significant career deviations, “he added.
Campbell apologized for bringing “negative light” to those who believe in him. He made his major league debut this season and was 0-2 with an 8.74 ERA in five games and 11 1/3 innings. He made a start for Miami last Saturday at the Washington Nationals and allowed four earned runs in 3 2/3 innings.
Marlins general manager Kim Ng said the organization was disappointed by the news of Campbell’s suspension.
Campbell is making the major league minimum of $ 570,500 this season and will lose about half of that amount.
“The Marlins support MLB’s ongoing efforts to maintain a level playing field for our athletes,” Ng said in a statement.